ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

Nutrition, Disease Oriented Contracts

December 4, 1981

In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group

September 17, 1976

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975